0001415889-23-003054.txt : 20230222 0001415889-23-003054.hdr.sgml : 20230222 20230222185845 ACCESSION NUMBER: 0001415889-23-003054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230217 FILED AS OF DATE: 20230222 DATE AS OF CHANGE: 20230222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Karam Sammy CENTRAL INDEX KEY: 0001766718 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 23655262 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 form4-02222023_110235.xml X0306 4 2023-02-17 0000001800 ABBOTT LABORATORIES ABT 0001766718 Karam Sammy 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 false true false false SENIOR VICE PRESIDENT Option (right to buy) 106.24 2023-02-17 4 A 0 45812 0 A 2024-02-17 2033-02-16 Common Shares 45812 45812 D Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,270 on February 17, 2024, 15,271 on February 17, 2025, and 15,271 on February 17, 2026. /s/ Sammy Karam by Jessica H. Paik, Attorney-in-Fact 2023-02-22